Dr. reddy's laboratories announces the launch of succinylcholine chloride injection usp, 200 mg/10 ml (20 mg/ml) in the u.s. market

Hyderabad, india & princeton, n.j.--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, along with its subsidiaries together referred to as “dr. reddy's”) today announced the launch of succinylcholine chloride injection usp, 200 mg/10 ml (20 mg/ml), multiple-dose vials a therapeutic equivalent generic version of quelicin® (succinylcholine chloride) injection, 20 mg/ml, approved by the u.s. food and drug administration (usfda). the quelicin® brand and generic ma
RDY Ratings Summary
RDY Quant Ranking